They create a promising drug against baldness

Baldness is common among men and its incidence increases as the years go by. About 50% of men over age 50 suffer from alopecia, according to the British Public Health Service.

British researchers have discovered that a drug to treat osteoporosis would be promising against baldness because it would stimulate the growth of osteoporosis.

As verified in the laboratory experts of the Center for Dermatological Research at the University of Manchester, the component called WAY-316606 would have a positive effect on the growth of hair follicles.

Scientists analyzed this impact on the scalp follicles given by 40 patients for a hair transplant. Thus, they found that this component reduces the expression of a protein called SFRP1 that has a negative role on the growth and development of many tissues, including the hair.

The researchers, led by Dr. Nathan Hawkshaw, consider that the external application on the human scalp of compounds similar to WAY-316606 could promote hair growth without side effects, says Informe21.

However, investigations are still ongoing and it would be necessary to conduct a clinical trial to ensure the total effectiveness and safety of this compound for people. These findings were recently published in the journal PLOS Biology.

Currently, there are two medications available to treat common baldness, called androgenic alopecia, which affects mostly men, but also some women. Minoxidil, which is prescribed for men and women, and finasteride, which is indicated only for men.

Both options have side effects and are not effective in 100% of cases, so patients are more concerned about the fall

We will have to wait a bit to see if they can finally find a drug that is effective and safe to fight against hair loss.